[Assessment of tissue viability for improvement of the left ventricular function after revascularization]

Radomir Matunović1, Aleksandar Stojanović, Zdravko Mijailović

  • 1Vojnomedicinska akademija, Beograd Klinika za kardiologiju. milaca@verat.net

Medicinski Pregled
|October 28, 2006
PubMed

Insights

Invasive revascularization significantly improves heart function and reduces cardiac deaths in heart failure patients post-myocardial infarction compared to drug therapy alone.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Echocardiography

Context:

  • Heart failure following myocardial infarction presents a significant clinical challenge.
  • Limited efficacy of current drug therapies and invasive revascularization.
  • Identifying viable myocardial tissue is crucial for treatment decisions.

Purpose:

  • To compare the effectiveness of invasive revascularization (CABG/PTCA) versus conventional drug therapy.
  • To evaluate outcomes in patients with heart failure post-myocardial infarction and viable myocardium.
  • To assess functional recovery and cardiac events over 12 months.

Summary:

  • A prospective study of 66 patients with heart failure post-myocardial infarction and reduced LVEF (<35%).
  • 34 patients underwent revascularization (CABG/PTCA); 32 received drug therapy.
  • Evaluated LVEF, WMSI, NYHA class, and cardiac death over 12 months.

Impact:

  • Revascularization significantly improved LVEF (37.84% vs. 33.14%) and reduced cardiac deaths (8.82% vs. 21.87%).
  • Patients undergoing revascularization showed better clinical status and WMSI (1.69 vs. 1.82).
  • Invasive procedures offer superior functional recovery and reduced cardiac events in selected patients.
Abstract